Secrest Blakey & Associates’s Pfizer PFE Stock Holding History

Secrest Blakey & Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$955K	Buy	27,424 +2,841	+12%	+$99.6K	2.18%	14
2020 Q2	$763K	Buy	24,583 +197	+0.8%	+$6.69K	1.84%	20
2020 Q1	$755K	Buy	24,386 +2,831	+13%	+$96.5K	2.06%	16
2019 Q4	$801K	Buy	21,555 +1,232	+6%	+$43.9K	1.76%	21
2019 Q3	$693K	Buy	20,323 +332	+2%	+$12.1K	0.57%	50
2019 Q2	$822K	Buy	19,991 +842	+4%	+$33.4K	0.72%	42
2019 Q1	$772K	Sell	19,149 -1,875	-9%	-$75.1K	0.75%	44
2018 Q4	$871K	Buy	21,024 +803	+4%	+$33.3K	0.73%	39
2018 Q3	$845K	Sell	20,221 -319	-2%	-$12.3K	0.65%	41
2018 Q2	$707K	Buy	20,540 +517	+3%	+$17.7K	0.56%	54
2018 Q1	$674K	Buy	20,023 +682	+4%	+$23.4K	0.58%	51
2017 Q4	$665K	Buy	+19,341	New	+$659K	0.54%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Secrest Blakey & Associates's PFE Position: Q3 2020 in Review

Secrest Blakey & Associates increased its Pfizer (PFE) stake by 12% in Q3 2020, buying an estimated $99.6K and bringing the position to 27,424 shares worth $955K. The position accounts for 2.18% of the portfolio, ranked #14.

Secrest Blakey & Associates first reported a position in PFE in Q4 2017 and has held it in 12 quarters since. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Secrest Blakey & Associates held 27,424 shares of Pfizer worth $955K as of Q3 2020.
Secrest Blakey & Associates bought 2,841 Pfizer shares in Q3 2020, an estimated $99.6K.
Pfizer made up 2.18% of Secrest Blakey & Associates's portfolio in Q3 2020, its #14 holding.
Secrest Blakey & Associates first reported a position in Pfizer in Q4 2017 and has held it in 12 quarters since.
2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.